FDA Clears IotaMotion’s Robotic CI Insertion System for Expanded Pediatric Use
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
The IotaSoft robotic-assisted cochlear implant insertion system is now cleared for use in children aged four and older.
A cochlear implant (CI) program in South Carolina has demonstrated how strategic workflow design, data-driven efficiency measures, and team-based care can dramatically expand access, improve patient satisfaction, and sustain rapid program growth in an underserved region.
The new Oticon Zeal combines an in-the-ear design with AI sound processing, rechargeability, and advanced connectivity options.
Summary:Sonitus Medical and BHM have formed a strategic partnership to globally commercialize...
Despite significant advances in cochlear implant technology and expanded candidacy criteria, access to these life-changing devices remains limited, prompting professionals to find new ways to close the gap in care.
Envoy Medical received FDA approval to begin a study of its fully implanted CI, which uses the ear’s natural anatomy to capture sound.